Margaret E. Olson

1.1k total citations
32 papers, 797 citations indexed

About

Margaret E. Olson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Margaret E. Olson has authored 32 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Margaret E. Olson's work include HIV Research and Treatment (3 papers), Enzyme function and inhibition (3 papers) and Opioid Use Disorder Treatment (3 papers). Margaret E. Olson is often cited by papers focused on HIV Research and Treatment (3 papers), Enzyme function and inhibition (3 papers) and Opioid Use Disorder Treatment (3 papers). Margaret E. Olson collaborates with scholars based in United States and Denmark. Margaret E. Olson's co-authors include M. Rabinovitz, Daniel A. Harki, David M. Greenberg, Reuben S. Harris, Kim D. Janda, Ibraheem M. Rajab, Lawrence A. Potempa, Lisa M. Eubanks, Peter C. Hart and Matthew L. Banks and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Margaret E. Olson

30 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret E. Olson United States 19 384 93 91 89 80 32 797
Hava Glickstein Israel 15 391 1.0× 82 0.9× 128 1.4× 82 0.9× 34 0.4× 23 1.6k
Takanobu Kikuchi Japan 19 687 1.8× 61 0.7× 118 1.3× 99 1.1× 68 0.8× 38 1.2k
Jay S. Hanas United States 23 1.0k 2.7× 72 0.8× 207 2.3× 59 0.7× 100 1.3× 69 1.7k
Maureen Highkin United States 14 274 0.7× 95 1.0× 84 0.9× 33 0.4× 33 0.4× 23 794
Nassima Oumata France 21 567 1.5× 90 1.0× 349 3.8× 170 1.9× 41 0.5× 43 1.1k
Mai Suzuki Japan 14 436 1.1× 74 0.8× 60 0.7× 36 0.4× 44 0.6× 52 789
Shuang Cao China 19 573 1.5× 96 1.0× 169 1.9× 86 1.0× 289 3.6× 59 1.1k
Enrica Bellesia Italy 13 436 1.1× 57 0.6× 107 1.2× 70 0.8× 136 1.7× 13 768
Ke‐He Ruan United States 23 733 1.9× 48 0.5× 110 1.2× 84 0.9× 98 1.2× 79 1.4k
Nívea Dias Amoêdo Brazil 19 632 1.6× 58 0.6× 134 1.5× 83 0.9× 355 4.4× 34 1.0k

Countries citing papers authored by Margaret E. Olson

Since Specialization
Citations

This map shows the geographic impact of Margaret E. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. Olson more than expected).

Fields of papers citing papers by Margaret E. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret E. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. Olson. The network helps show where Margaret E. Olson may publish in the future.

Co-authorship network of co-authors of Margaret E. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret E. Olson. A scholar is included among the top collaborators of Margaret E. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret E. Olson. Margaret E. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Olson, Margaret E., et al.. (2023). Activation of Adrenoceptor Alpha-2 (ADRA2A) Promotes Chemosensitization to Carboplatin in Ovarian Cancer Cell Lines. Current Issues in Molecular Biology. 45(12). 9566–9578. 4 indexed citations
3.
4.
Potempa, Lawrence A., Ibraheem M. Rajab, Margaret E. Olson, & Peter C. Hart. (2021). C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms. Frontiers in Immunology. 12. 744129–744129. 43 indexed citations
5.
Olson, Margaret E., et al.. (2021). SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies. The International Journal of Neuropsychopharmacology. 25(1). 1–12. 11 indexed citations
6.
Lin, Lucy, Margaret E. Olson, Alexander L. Nielsen, et al.. (2020). Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A. Journal of Medicinal Chemistry. 63(19). 11100–11120. 15 indexed citations
7.
Olson, Margaret E., et al.. (2019). Consequence of Hapten Stereochemistry: An Efficacious Methamphetamine Vaccine. Journal of the American Chemical Society. 141(36). 14089–14092. 13 indexed citations
8.
Lin, Lucy, Margaret E. Olson, Lisa M. Eubanks, & Kim D. Janda. (2019). Strategies to Counteract Botulinum Neurotoxin A: Nature’s Deadliest Biomolecule. Accounts of Chemical Research. 52(8). 2322–2331. 24 indexed citations
9.
Banks, Matthew L., Margaret E. Olson, & Kim D. Janda. (2018). Immunopharmacotherapies for Treating Opioid Use Disorder. Trends in Pharmacological Sciences. 39(11). 908–911. 26 indexed citations
10.
Kimishima, Atsushi, Margaret E. Olson, & Kim D. Janda. (2017). Investigations into the efficacy of multi-component cocaine vaccines. Bioorganic & Medicinal Chemistry Letters. 28(16). 2779–2783. 5 indexed citations
11.
Olson, Margaret E., Reuben S. Harris, & Daniel A. Harki. (2017). APOBEC Enzymes as Targets for Virus and Cancer Therapy. Cell chemical biology. 25(1). 36–49. 117 indexed citations
12.
Olson, Margaret E. & Kim D. Janda. (2017). Vaccines to combat the opioid crisis. EMBO Reports. 19(1). 5–9. 21 indexed citations
13.
Olson, Margaret E., et al.. (2016). Rapid, microwave accelerated synthesis of [1,2,4]triazolo[3,4- b ][1,3,4]oxadiazoles from 4-acylamino-1,2,4-triazoles. Tetrahedron Letters. 57(36). 4056–4060. 3 indexed citations
14.
Brand, Lucas J., Margaret E. Olson, Preethi Ravindranathan, et al.. (2015). EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. Oncotarget. 6(6). 3811–3824. 58 indexed citations
15.
Olson, Margaret E., Ming Li, Reuben S. Harris, & Daniel A. Harki. (2012). Small‐Molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4‐Amino‐1,2,4‐triazole‐3‐thiol Scaffold. ChemMedChem. 8(1). 112–117. 36 indexed citations
16.
White, Brian R., et al.. (2012). Inhibition of Guanosine Monophosphate Synthetase by the Substrate Enantiomer L‐XMP. ChemBioChem. 13(17). 2517–2520.
17.
Olson, Margaret E., et al.. (2009). A mild and chemoselective method for the deprotection of tert-butyldimethylsilyl (TBDMS) ethers using iron(III) tosylate as a catalyst. Tetrahedron Letters. 51(7). 1056–1058. 21 indexed citations
18.
Rabinovitz, M. & Margaret E. Olson. (1959). Protein Synthesis by Rabbit Reticulocytes. Journal of Biological Chemistry. 234(8). 2085–2090. 37 indexed citations
19.
Rabinovitz, M., Margaret E. Olson, & David M. Greenberg. (1957). CHARACTERISTICS OF THE INHIBITION BY ETHIONINE OF THE INCORPORATION OF METHIONINE INTO PROTEINS OF THE EHRLICH ASCITES CARCINOMA IN VITRO. Journal of Biological Chemistry. 227(1). 217–224. 28 indexed citations
20.
Rabinovitz, M., Margaret E. Olson, & David M. Greenberg. (1954). INDEPENDENT ANTAGONISM OF AMINO ACID INCORPORATION INTO PROTEIN. Journal of Biological Chemistry. 210(2). 837–849. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hava Glickstein Breakdown of academic impact, for papers by Takanobu Kikuchi Breakdown of academic impact, for papers by Jay S. Hanas Breakdown of academic impact, for papers by Maureen Highkin Breakdown of academic impact, for papers by Nassima Oumata Breakdown of academic impact, for papers by Mai Suzuki Breakdown of academic impact, for papers by Shuang Cao Breakdown of academic impact, for papers by Enrica Bellesia Breakdown of academic impact, for papers by Ke‐He Ruan Breakdown of academic impact, for papers by Nívea Dias Amoêdo
Rankless by CCL
2026